Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
Flagship's Noubar Afeyan on uncertainty, AI and biotech’s future
10 months ago
Financing
Updated: Flagship reels in $3.6B to create 25 new companies
10 months ago
Financing
Are 'next-gen' biotech acquirers experiencing their moment?
10 months ago
Deals
Pharma
Exclusive: Courier Health raises $16.5M Series A to help biopharma companies bring together patient data
10 months ago
Health Tech
Biovance debuts with €51M to lift up biotech scene in Portugal and southern Europe
10 months ago
Financing
Exclusive: Gene insertion startup launches with new integrase technology from University of Hawaii
10 months ago
Financing
Cell/Gene Tx
VC firm emerges to boost Austrian biotech scene that’s ‘ready to break out’
10 months ago
Financing
In pivot to buzzy ADCs, London biotech Myricx raises $114M with Lilly's support
10 months ago
Financing
Circle Pharma raises $54M as part of Series D while macrocycles heat up
10 months ago
Financing
In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024
10 months ago
Financing
Flagship appears to boost target of eighth fund by up to $500M
10 months ago
Financing
Beacon raises $170M to take on J&J in ocular gene therapy
10 months ago
Financing
Cell/Gene Tx
Artiva refiles for IPO three years after original plans in a vastly different environment
10 months ago
Financing
Immunology biotech Alumis secures $250M in shrunken IPO
11 months ago
Financing
One Medical CEO-turned-VC wants startups that are 'disruptive from within the ecosystem'
11 months ago
Financing
Health Tech
Exclusive: To develop better cell therapies for solid tumors, a new startup plans to test hundreds of them at once
11 months ago
Financing
Longevity investors look to add $200M to the table with new growth fund
11 months ago
Financing
Maze spins its ALS antisense program into a secretive new company
11 months ago
Deals
Alexis Borisy and Zach Weinberg's Curie.Bio secures $380M to support portfolio's Series A rounds
11 months ago
Financing
Exclusive: Cityblock Health investors buy employee shares in tender offer
11 months ago
Financing
Health Tech
New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi
11 months ago
Financing
Ex-Meta scientists launch EvolutionaryScale with $142M seed round, unveiling next-gen AI model for protein design
11 months ago
Financing
R&D
Can mRNA be harnessed for gene insertion? Moderna's former chief medical officer has $82M to find out
11 months ago
Financing
Cell/Gene Tx
Schizophrenia biotech LB Pharmaceuticals eyes near-term IPO filing — source
11 months ago
Financing
First page
Previous page
13
14
15
16
17
18
19
Next page
Last page